Dr. Leonard on Treating Relapsed Patients With Follicular Lymphoma

John P. Leonard, MD
Published: Thursday, May 12, 2016



John P. Leonard, MD, medical oncology, Weill Cornell Medicine and New-York Presbyterian, discusses treatment considerations for relapsed patients with follicular lymphoma.

Approximately 80% of patients with follicular lymphoma will likely not die from their disease, but with their disease, Leonard explains. Several ongoing studies show that early treatment does not necessarily improve long-term outcomes.

Factors that influence treatment choices include bulk of disease, symptoms, and asymptomatic progression, Leonard adds.


John P. Leonard, MD, medical oncology, Weill Cornell Medicine and New-York Presbyterian, discusses treatment considerations for relapsed patients with follicular lymphoma.

Approximately 80% of patients with follicular lymphoma will likely not die from their disease, but with their disease, Leonard explains. Several ongoing studies show that early treatment does not necessarily improve long-term outcomes.

Factors that influence treatment choices include bulk of disease, symptoms, and asymptomatic progression, Leonard adds.

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast CancerMay 30, 20182.0
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of CancersMay 30, 20181.5
Publication Bottom Border
Border Publication
x